Skip to main content

Hispanics in Treatment: The Loxapine Experience

  • Chapter
Psychiatry The State of the Art

Abstract

Since 1975 the authors have been using Loxapine Succinate/ Hydrochloride [Loxitane (R)] in a variety of psychotic disorders such as Acute and Paranoid Schizophrenia, Bipolar Disorder, specifically the Manic Phase, in conjunction with Lithium Carbonate, Acute and Chronic Brain disorder and/or any psychotic disorder where loss of contact with reality (delusions and hallucinations) and agitation are cardinal symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Davis, J.M. and Casper, R.: Antipsychotic drugs; Clinical Pharmacology and therapeutic use. Drugs 14: 260–282. 1977.

    Article  PubMed  CAS  Google Scholar 

  2. Ayd FJ Jr. Loxapine update: 1966–1976. Dis Nerv Syst 38:883–887, 1977.

    PubMed  Google Scholar 

  3. Gomez, E., “Comparison of Loxapine, Chlorpromazine and Placebo,” Grand Rounds, George London Mem. Hosp. Chicago, IL, June 1976,

    Google Scholar 

  4. Gomez, E., “Loxapine vs. Haloperidol, Clinical Observations in Acute Schizophrenia,” paper read at Clinical Conference, George London Memorial Hospital, Chicago, IL, November 1976.

    Google Scholar 

  5. Arce, A., Torres-Matrullo, C, “Acculturation: Its Impact on Treatment Strategies,” paper read “The Hispanic American Symposium,” A.P.A. Annual Meeting, Atlanta, GA, May 1978.

    Google Scholar 

  6. Gomez, E., “Clinical Observations In The Treatment of Tardive Dyskinesia with Dihydrogenated Ergot Alkaloids (Hydergine), Preliminary Findings,” Psych. J. Univ. Ottawa, Vol. II, No. 2, July 1977.

    Google Scholar 

  7. Gomez, E., “The Chronic Patient, Patterns of Rehabilitation,” paper read to the Faculty Ottawa University — School of Medicine, Dept. of Psychiatry, Ottawa, Canada, March 1982.

    Google Scholar 

  8. Hollister, L.E.: Uses of Psychotherapeutic Drugs. Ann. Int. Med. 79:88–98, 1973.

    Article  PubMed  CAS  Google Scholar 

  9. Tune, LE, McHugh PR, Coyle JT: Management of extrapyramidal side effects. induced by neuroleptics. Johns Hopkins Med J 148:149–153, 1981.

    PubMed  CAS  Google Scholar 

  10. Cole, J. O.: Therapeutic approaches to tardive dyskinesia. Arch. Gen. Psychiat. 27:491–499, 1972.

    Article  PubMed  Google Scholar 

  11. Weidley EF, Setler PE, Rush JA:

    Google Scholar 

  12. Clark ML, Paredes A. Costiloe JP, et al: Loxapine in newly admitted chronic schizophrenic patients. J Clin Pharmacol 15:286–292, 1975.

    Article  PubMed  CAS  Google Scholar 

  13. Gomez, M., Gomez, E., “Hispanics in Treatment: The Amoxapine Experience,” paper read at the Symposium “The Treatment of Hispanic Patients in the U.S.A.” at the VII World Congress of Psychiatry, Vienna, Austria, July 198.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gomez, E., Gomez, M. (1985). Hispanics in Treatment: The Loxapine Experience. In: Pichot, P., Berner, P., Wolf, R., Thau, K. (eds) Psychiatry The State of the Art. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1853-9_75

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-1853-9_75

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-1855-3

  • Online ISBN: 978-1-4757-1853-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics